封面
市场调查报告书
商品编码
1548114

全球胜肽合成市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Peptide Synthesis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

预计到2032年,全球胜肽合成市场的市场规模将从2023年的6.9069亿美元达到近22.639亿美元,2024-2032年研究期间的复合年增长率为14.1%。

胜肽具有广泛的生物功能,例如抗氧化特性、荷尔蒙功能、抗菌剂、临床诊断,并且还可作为生长因子。此外,由于其特异性高、化学空间大、易于合成、生物活性、低毒性和易于获得,它们也作为潜在的活性药物成分用于药物开发。它们也被用于治疗多种疾病,包括心血管疾病、癌症、呼吸系统疾病等。由于胜肽生产中的各种技术进步,肽分子在营养和医疗保健行业中获得了巨大的发展动力。例如,化学合成被认为是传统且广泛使用的胜肽合成技术;然而,该过程缺乏特异性,增加了环境负担的风险。因此,这导致了酶法技术用于肽合成的应用。

市场动态

肽在药品生产中的使用不断增加推动了市场的成长。肽是具有多种生物功能的高度特异性和活性药物,被广泛应用于治疗领域。糖尿病、肿瘤学和肥胖症是胜肽产生数十亿美元利润的三大治疗领域。根据美国国家癌症研究所的研究,2018年美国诊断出1,735,350例癌症病例。因此,疾病状况的上升推动了全球胜肽合成市场的成长。此外,肽合成市场研发活动的增加也有助于市场成长。为了克服全球健康挑战,研究实体的参与和对先进创新生物基产品的投资不断增加,对市场成长产生了积极影响。然而,胜肽合成过程中的污染问题加上监管标准缺乏升级,限制了市场的发展。多家公司正在开发先进的胜肽生产技术,预计在未来几年为市场创造利润丰厚的机会。例如,New England Peptide Inc.使用名为Pep Trend系统的独特软体程式来设计和生产客製化胜肽。

该报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。

此外,这些工具还对全球肽合成市场中的每个应用/产品领域进行包容性评估。

市场区隔

整个胜肽合成市场已细分为产品、应用、技术和最终用户。该报告根据地理细分对这些子集进行了分析。这项研究将使行销人员了解情况,并有助于确定产品或服务的目标族群。

按产品分类

  • 设备(胜肽合成仪、冷冻干燥机、层析设备等)
  • 试剂及耗材
  • 其他

依技术

  • 固相胜肽合成(SPPS)
  • 液相肽合成 (LPPS)
  • 混合技术

按申请

  • 治疗学(癌症、代谢、心血管疾病、呼吸系统、GIT(胃肠道疾病)、传染病、疼痛、皮肤科、中枢神经系统、肾臟、其他)
  • 诊断
  • 研究

按最终用途

  • 製药与生物技术公司
  • 合约开发和製造组织/合约研究组织
  • 学术及研究机构
  • 区域分析

本节涵盖区域细分,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的胜肽合成市场当前和未来的需求。此外,该报告重点关注所有主要地区对个别应用领域的需求。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。胜肽合成市场的主要参与者包括Genscript Biotech、Merck KGaA、Bachem Holdings、Biotage、CEM Corporation、Thermo Fisher、Creative Diagnostics、Polypeptide Group、Syngene、PuroSynth、Lonza、MP Biomedicals 和Novo Nordisk A/S。本节包括竞争格局的整体视图,其中包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:胜肽合成 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 按技术分類的市场吸引力分析
    • 市场吸引力分析:依应用分类
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球胜肽合成市场分析:按产品

  • 概述(按产品)
  • 历史和预测数据
  • 按产品分析
  • 设备(胜肽合成仪、冷冻干燥机、层析设备等)
  • 试剂及耗材
  • 其他

第 6 章:全球胜肽合成市场分析:依技术分类

  • 依技术概述
  • 历史和预测数据
  • 技术分析
  • 固相胜肽合成(SPPS)
  • 液相肽合成 (LPPS)
  • 混合技术

第 7 章:全球胜肽合成市场分析:按应用分类

  • 概述:按应用
  • 历史和预测数据
  • 分析:按应用
  • 治疗学(癌症、代谢、心血管疾病、呼吸系统、GIT(胃肠道疾病)、传染病、疼痛、皮肤科、中枢神经系统、肾臟、其他)
  • 诊断
  • 研究

第 8 章:全球胜肽合成市场分析:依最终用途

  • 按最终用途分类的概述
  • 历史和预测数据
  • 按最终用途分析
  • 製药与生物技术公司
  • 合约开发和製造组织/合约研究组织
  • 学术及研究机构

第 9 章:全球胜肽合成市场分析:依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第10章:胜肽合成公司的竞争格局

  • 多肽合成市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Genscript Biotech
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck KGaA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bachem Holdings
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Biotage
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • CEM Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Thermo Fisher
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Creative Diagnostics
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Polypeptide Group
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Syngene
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • PuroSynth
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Lonza
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • MP Biomedicals And Novo Nordisk A/S.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中,财务详细资讯和最新发展视情况而定,或对私人公司而言可能不包括在内

Product Code: VMR11211390

The global demand for Peptide Synthesis Market is presumed to reach the market size of nearly USD 2263.9 Million by 2032 from USD 690.69 Million in 2023 with a CAGR of 14.1% under the study period 2024 - 2032.

Peptides possess broad range of biological functions such as anti-oxidant properties, hormonal functions, antimicrobial agents, clinical diagnosis, and also act as growth factors. Furthermore, they are also used in drug development as potential active pharmaceutical ingredients owing to their high specificity, large chemical space, ease of synthesis, biological activity, low toxicity, and ready availability. They are also exploited in the treatment of several diseases including cardiovascular diseases, cancer, respiratory disorders, and others. Peptide molecules gained immense momentum in nutrition and healthcare industries attributed to the various technological advancements in the peptide production. For instance, chemical synthesis is considered as the traditional and widely used technology for peptide synthesis; however, the process lacked specificity and increased the risk of environmental burdens. Therefore, this caused the adoption of enzymatic technology for peptide synthesis.

Market Dynamics

Escalating usage of peptides in the production of pharmaceutical drugs propels the market growth. Peptides are highly specific and active drugs with diverse biological functions that are used in a broad range of therapeutic areas. Diabetes, oncology, and obesity are the three major therapeutic areas in which peptides generate profits in billions of dollars. According to the research study by National Cancer Institute, 1,735,350 cancer cases were diagnosed in the U.S in 2018. Additionally, owing to the growing sedentary lifestyle among populace increases the chances of obesity. Therefore, rising disease conditions boost the growth of global peptide synthesis market. Moreover, the increase in research & development activities in the peptide synthesis market also contributes to the market growth. The rising participation of research entities and investment for the advanced and innovative bio-based products in order to overcome the global health challenges positively influences the market growth. However, contamination issues during the course of peptide synthesis coupled with lack of upgradation in regulatory standards acts as a restrain for the market progression. Various companies are developing advanced technologies for peptide production, and it is anticipated to create lucrative opportunities for the market in the coming years. For example, New England Peptide Inc. uses a unique software program named Pep Trend system, to design and produce custom peptides.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of peptide synthesis.

Market Segmentation

The entire peptide synthesis market has been sub-categorized into product, application, technology and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Product

  • Equipment (Peptide Synthesizers, Lyophilizers, Chromatography Equipment, Others)
  • Reagents & Consumables
  • Other

By Technology

  • Solid Phase Peptide Synthesis (SPPS)
  • Liquid Phase Peptide Synthesis (LPPS)
  • Hybrid Technology

By Application

  • Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others)
  • Diagnosis
  • Research

By End-use

  • Pharmaceutical & Biotechnology Companies
  • Contract Development & Manufacturing Organization/Contract Research Organization
  • Academic & Research Institutes
  • Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for peptide synthesis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the peptide synthesis market include Genscript Biotech, Merck KGaA, Bachem Holdings, Biotage, CEM Corporation, Thermo Fisher, Creative Diagnostics, Polypeptide Group, Syngene, PuroSynth, Lonza, MP Biomedicals and Novo Nordisk A/S. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PEPTIDE SYNTHESIS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-use
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Equipment (Peptide Synthesizers, Lyophilizers, Chromatography Equipment, Others) Historic and Forecast Sales By Regions
  • 5.5. Reagents & Consumables Historic and Forecast Sales By Regions
  • 5.6. Other Historic and Forecast Sales By Regions

6. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY TECHNOLOGY

  • 6.1. Overview By Technology
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Technology
  • 6.4. Solid Phase Peptide Synthesis (SPPS) Historic and Forecast Sales By Regions
  • 6.5. Liquid Phase Peptide Synthesis (LPPS) Historic and Forecast Sales By Regions
  • 6.6. Hybrid Technology Historic and Forecast Sales By Regions

7. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Application
  • 7.4. Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others) Historic and Forecast Sales By Regions
  • 7.5. Diagnosis Historic and Forecast Sales By Regions
  • 7.6. Research Historic and Forecast Sales By Regions

8. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY END-USE

  • 8.1. Overview By End-use
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By End-use
  • 8.4. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
  • 8.5. Contract Development & Manufacturing Organization/Contract Research Organization Historic and Forecast Sales By Regions
  • 8.6. Academic & Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL PEPTIDE SYNTHESIS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PEPTIDE SYNTHESIS COMPANIES

  • 10.1. Peptide Synthesis Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF PEPTIDE SYNTHESIS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Genscript Biotech
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Merck KGaA
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Bachem Holdings
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Biotage
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. CEM Corporation
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Thermo Fisher
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Creative Diagnostics
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Polypeptide Group
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Syngene
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. PuroSynth
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Lonza
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. MP Biomedicals And Novo Nordisk A/S.
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Equipment (Peptide Synthesizers, Lyophilizers, Chromatography Equipment, Others) Market Sales By Geography (USD MN)
  • Reagents & Consumables Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Technology (USD MN)
  • Solid Phase Peptide Synthesis (SPPS) Market Sales By Geography (USD MN)
  • Liquid Phase Peptide Synthesis (LPPS) Market Sales By Geography (USD MN)
  • Hybrid Technology Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others) Market Sales By Geography (USD MN)
  • Diagnosis Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Contract Development & Manufacturing Organization/Contract Research Organization Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Peptide Synthesis Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Peptide Synthesis Report
  • Market Research Process
  • Market Research Methodology
  • Global Peptide Synthesis Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Equipment (Peptide Synthesizers, Lyophilizers, Chromatography Equipment, Others) Market Sales By Geography (USD MN)
  • Reagents & Consumables Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Technology (USD MN)
  • Solid Phase Peptide Synthesis (SPPS) Market Sales By Geography (USD MN)
  • Liquid Phase Peptide Synthesis (LPPS) Market Sales By Geography (USD MN)
  • Hybrid Technology Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Therapeutics (Cancer, Metabolic, Cardiovascular Disorder, Respiratory, GIT (Gastrointestinal Disorders), Infectious Diseases, Pain, Dermatology, CNS, Renal, Others) Market Sales By Geography (USD MN)
  • Diagnosis Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Contract Development & Manufacturing Organization/Contract Research Organization Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.